Dave Helsel

This profile gathers the share dealings of Dave Helsel in Angiodynamics Inc, where the filings describe the role as senior executive. We count 16 filings; the first trade dates from 14 July 2021 and the latest from 21 July 2023.

On the market, this insider has only sold: 4 sales, €324k in total. Besides market trades, the filings include 7 share grants and 5 option exercises. 2023 to date brings no purchases and 1 sale.

On 21 September 2023 came the latest disclosure, an option exercise in Angiodynamics Inc. Typically, a trade is published a median of 4 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.